ZONEFOR SB
General Range

ZONEFOR SB

Fortune LabsPanchkula, Haryana

Price on request/100 · MOQ 100 boxes

ZONEFOR SB Injection by Fortune Labs contains Cefoperazone and Sulbactam, a broad-spectrum antibiotic combination used to treat serious bacterial infections caused by susceptible microorganisms. Cefoperazone is a third-generation cephalosporin antibiotic that inhibits bacterial cell wall synthesis, while Sulbactam helps protect it against certain bacterial beta-lactamase enzymes. ZONEFOR SB may be prescribed for respiratory tract infections, pneumonia, urinary tract infections, intra-abdominal infections, and skin infections when clinically appropriate. Available in a 1.5 gm single-dose vial, this formulation is part of Fortune Labs' injectable pharmaceutical portfolio. Fortune Labs offers Injection PCD Pharma Franchise and distribution opportunities across India. Contact the company for wholesale pricing, product availability, and franchise enquiries. Administer only under qualified medical supervision.

CategoryGeneral Range
Min. Order100 boxes
Supplied byFortune Labs
CertificationWHO-GMP, ISO

Prices are indicative and set by the listing company. Confirm net rates, packing and stock availability directly with the supplier.

View Company

Specifications

Composition
Cefoperazone 1000 mg (1 gm) + Sulbactam 500 mg
Packaging Type
Glass Vial with 10 ml Sterile Water Ampoule and Outer Carton
Packaging Size
1.5 gm Single-Dose Vial
Dosage Form
Injectable Solution
Treatment
Bacterial respiratory tract infections, pneumonia, urinary tract infections, intra-abdominal infections, skin and soft tissue infections, and other se
Shelf Life
24 Months
Storage
Store below 30°C, protect from light & moisture
Certification
WHO-GMP, ISO

Company Info

Fortune LabsPanchkula, Haryana
View Full Profile

Fortune Labs is an Indian pharmaceutical and PCD (Propaganda Cum Distribution) pharma franchise company based in Panchkula, Haryana.

Key Details

• Headquarters: S.C.F 258, 1st Floor, Sector 16, Panchkula, Haryana, India
• Establishment: Founded in 2008 (sister concern of Prosperity 6 Pharmaceutics in Baddi)
• CEO / Leadership: Mayank Bansal
• Certifications: ISO 9001, WHO-GMP, and DCGI-approved formulations
• Business Model: Offers Pan-India PCD pharma franchises with monopoly rights, third-party manufacturing, and marketing support.

Product Portfolio & Therapeutic Ranges

• Formulations: Tablets, capsules, syrups, dry powders, injectables, ointments, gels, eye/ear/nasal drops, softgel capsules, and Ayurvedic/herbal products.
• Therapeutic Segments: Antibiotics, cardiac and diabetic care, orthopedics, dermatology, gynaecology, paediatrics, gastrointestinal/PPI ranges, neurology, antihistamines/cough-cold, and nutritional supplements.
Would you like information on how to apply for a franchise partnership or specific product price lists from Fortune Labs?

More General Range